🔎 Trials Near Me

Pradžia › Minkštųjų audinių sarkoma › Masčusetsas › Boston

Minkštųjų audinių sarkoma klinikiniai tyrimai Boston, MA

18 tyrimai dėl Minkštųjų audinių sarkoma ieško dalyvių vietose Boston ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Distance-Based Exercise to Preserve Function and Prevent Disability

Renkami dalyviai
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07059884

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Renkami dalyviai2 fazė
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06760819

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Renkami dalyviai1/2 fazė
  • Dana Farber Cancer Institute., Boston
Iki 25 metų · Visoms lytims · Atnaujinta 2026-09-25 · NCT04094610

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Renkami dalyviai1 fazė
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT06641908

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Renkami dalyviai1/2 fazė
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT05732831

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

Renkami dalyviai1 fazė
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT06644755

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Renkami dalyviai1 fazė
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT05711615

Serial MRI Scans During Radiation Therapy

Renkami dalyviai
  • Brigham and Women Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT04188535

Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention

Renkami dalyviai
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Amžius nuo 15 iki 39 · Visoms lytims · Atnaujinta 2026-08-26 · NCT07662239

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Renkami dalyviai1/2 fazė
  • Dana Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT06975293

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Renkami dalyviai1/2 fazė
  • Dana Farber Cancer Institute, Boston
Iki 30 metų · Visoms lytims · Atnaujinta 2026-08-03 · NCT06239272

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Renkami dalyviaiStebimasis tyrimas
  • Brigham and Women's Hospital, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-15 · NCT07377747

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Renkami dalyviaiStebimasis tyrimas
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-30 · NCT07675967

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Renkami dalyviai1/2 fazė
  • Massachusetts General Hospital,, Boston
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-05-27 · NCT03093116

Video Education With Result Dependent dIsclosure

Renkami dalyviai
  • Dana Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-22 · NCT05225428

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Renkami dalyviai1/2 fazė
  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
Amžius nuo 12 iki 49 · Visoms lytims · Atnaujinta 2026-02-19 · NCT06709495

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Renkami dalyviai1/2 fazė
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-08 · NCT04370587

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Renkami dalyviaiStebimasis tyrimas
  • Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2019-02-12 · NCT03838718

Minkštųjų audinių sarkoma tyrimai kituose miestuose

Kiti tyrimai Boston

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.